• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Academy
  • FAQ
  • News
  • Blog
  • Europe
    • United Kingdom
    • Spain
    • Italy
    • Portugal
    • Brazil
    • Colombia
    • Ecuador
    • Mexico
    • Argentina
    • Latin America
    • UAE
Veritas

Veritas

  • Services and Test
        • Preventive Medicine
        • Pregnancy & Early Childhood
        • Diagnostic Genetics Services
        • Genetic Counselling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • CONTACT
LlámanosLlámanos
CALL US!
  • Europe

  • United Kingdom

  • Spain

  • Italy

  • Brazil

  • Portugal

  • Colombia

  • Ecuador

  • Mexico

  • Argentina

  • Latin America

  • Services & Test
    • Preventive Medicine
      • myGenome
      • myGeneticRisk
      • myHealthScore
    • Pregnancy & Early Childhood
      • myPrenatal
      • myNewborn
      • myBabyHealth
      • myPrenatal WES
    • Genetics Diagnostics
      • myCardio
      • myCancerRisk
      • GenomeDx
      • ExomeDx
      • myDiagnostic
    • Genetic Counseling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • Academy
  • FAQ
  • News
  • Blog
  • Contact

myPrenatal

myPrenatal

The most comprehensive non-invasive prenatal test (NIPT) available

Veritas offers a new generation of Non-Invasive Prenatal Test (NIPT), maximizing the screening performance for common trisomies. The test also provides other analysis options to expand the screening including relevant alterations in the fetal genome.

From the 10th week of gestation​

For singleton and twin pregnancies​

With a blood sample from the mother​

Results in​
5 working​
days​

Suitable for pregnancies through assisted 
Reproductive
 techniques, even in cases of gamete donation

Genomic 
screening options​

What is myPrenatal?

The study of the most frequent chromosomal abnormalities: Down, Edwards and Patau syndromes (trisomies 21, 18 and 13), together with sex chromosome alterations.

The myPrenatal bioinformatics algorithm evaluates fetal fraction and sequencing depth together, achieving the best performance in all cases. In the presence of low fetal fraction, if there is an appropriate sequencing depth, it is possible to deliver results with the same performance as in cases with higher fetal fraction. If the fetal fraction is high, the analysis requires a lower sequencing depth.

Additionally, the test allows the expansion of the study to include:

  • Large deletions and duplications (CNVs) of more than 7 Mb, alterations that can cause different fetal malformations associated with delayed cognitive development.
  • Aneuploidies in all chromosomes, associated with fetal loss and other structural alterations.

myPrenatal Options

myPrenatal is offered in three different options

myPrenatal

myPrenatal – XY

myPrenatal – GenomeScreen

Chromosomes 21, 18, 13

Fetal sex

Optional

Sex chromosomes (X and Y)

Deletions and duplications (CNVs) > 7Mb

Other autosomal chromosomes

Optional

The options myPrenatal and myPrenatal GenomeScreen are also available for twin pregnancies

Why should I choose myPrenatal?​

  • New NIPT generation, which allows a more comprehensive chromosomal analysis, including large deletions and duplications (over 7Mbs) in the fetal DNA.​
  • Paired-end sequencing allows a more accurate fetal fraction determination and improves the bioinformatic analysis after sequencing.
  • The test issues highly reliable results even in cases of samples with low fetal fraction, thanks to the sequencing method and the bioinformatic algorithm.
  • Advanced options available also for twin pregnancies and egg donation.​ Includes genetic counselling to support the specialist, if requested.

Are you interested in offering myPrenatal from Veritas?

Contact us and find out how we can work together.

CONTACT US
MEDICAL BROCHURE

Are you interested in myPrenatal but you do not have a doctor that provides the service?

Our medical professionals can help you. Please click on the below button to learn more.

FIND OUT MORE
PATIENT BROCHURE

Advantages of myPrenatal

myPrenatal provides greater accuracy than traditional combined screening by avoiding unnecessary invasive procedures, which can put the health of mother and baby at risk.

myPrenatal assesses the risk of a complete list of severe diseases that can impact the first stages of life for a newborn.

With a simple maternal blood sample, with no risk to the mother or the baby.

Greater accuracy than combined screening tests, reducing unnecessary invasive procedures.

Results in 5 working days, from the reception of the sample in our laboratory.

The test is performed in our laboratories located in Europe by an experienced team and is CE marked.

A team of specialists with more than 20 years of experience in prenatal diagnosis and genetic counselling.

The Veritas team has pioneered the development and introduction of non-invasive prenatal testing in Europe, which is now revolutionising the market again with myPrenatal GenomeScreen.

Advice to the specialist

Veritas offers a differential service by providing advice to the specialist for the interpretation of your patient’s results, whenever you need it.

Are you a medical professional?

If you want more technical information about myPrenatal you can download the medical brochure:

DOWNLOAD

Frequently asked questions about myPrenatal

How does myPrenatal work?

myPrenatal is a genetic sequencing test that is performed from a simple maternal blood sample (like any routine blood test) from which we extract free fetal DNA. All our tests must be prescribed by a physician, and include pre- and post-test genetic counseling.

Is myPrenatal suitable for all types of pregnancies?

myPrenatal is a test for pregnant women from the tenth week of gestation, it is possible to perform myPrenatal in single or twin pregnancies and in cases of in vitro fertilization through ovodonation.

SEE ALL QUESTIONS

Footer

  • facebook
  • youtube
  • twitter
  • instagram
  • linkedin

VERITAS INTERCONTINENTAL – Pº DE LA CASTELLANA 101 – BAJO 1, 28046 MADRID, ESPAÑA – CIF B88132907 – CENTRO MÉDICO AUTORIZADO Registro Nº CS15664

  • Privacy policy and Legal notice
  • General contracting conditions
  • Cookies Policy